Corpus Intelligence IC Memo — VISTA HEALTH TEXARKANA 2026-04-26 10:39 UTC
IC Memo — VISTA HEALTH TEXARKANA
Investment Committee Memorandum | AR | 50 beds | Grade C | EBITDA uplift $870K
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

VISTA HEALTH TEXARKANA

CCN 044020 | MILLER, AR | 50 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

VISTA HEALTH TEXARKANA is a 50-bed suburban community hospital in MILLER, AR with $11.8M in net patient revenue and a -1.1% operating margin. The hospital serves a payer mix of 8.1% Medicare, 4.3% Medicaid, and 87.6% commercial.

Thesis: Turnaround. Our ML models identify $870K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -1.1% to 6.3% (+739bps).

Net Revenue HCRIS$11.8M
Current EBITDA COMPUTED$-130K
Operating Margin COMPUTED-1.1%
Occupancy HCRIS66.4%
Revenue / Bed COMPUTED$235K
Net-to-Gross HCRIS48.8%
Distress Probability ML46.9%

2. Market Context & Competitive Position

108
AR Hospitals
-7.6%
State Median Margin
59
Comparable Hospitals

AR has 108 Medicare-certified hospitals with a median operating margin of -7.6%. The target's margin of -1.1% places it above the state median. Among 59 size-comparable peers (25-100 beds), the median margin is -13.9%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (25-100), prioritizing same-state peers. 59 hospitals in the comp set.

HospitalStateBedsRevenueMargin
VISTA HEALTH TEXARKANA (Target)AR50$11.8M-1.1%
SILOAM SPRINGS MEMORIAL HOSPITAR64$85.0M8.4%
ARKANSAS SURGICAL HOSPITALAR47$75.1M11.7%
ST VINCENT NORTHAR68$72.1M-18.7%
ENCORE MEDICAL CENTERAR25$55.7M-4.7%
OZARKS COMMUNITY HOSPITAL OF GAR25$48.6M-21.0%
ENCOMPASS HEALTH REHABILITATIOAR80$36.3M27.9%
DREW MEMORIAL HOSPITAL INCAR49$35.3M-27.2%
ASHLEY COUNTY MEDICAL CENTERAR25$33.7M-23.0%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $870K (739bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$247K+210bp18mo
Cost to Collect4.5%2.5%$235K+200bp12mo
Denial Rate Reduction12.0%6.5%$235K+200bp12mo
A/R Days Reduction5200.0%3800.0%$143K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+8bp6mo

5. EBITDA Bridge

Net Collection Rate
$247K
Cost to Collect
$235K
Denial Rate Reduction
$235K
A/R Days Reduction
$143K
Clean Claim Rate
$10K
Total EBITDA Uplift$870K
Current EBITDA$-130K
+ RCM Uplift+$870K
Pro Forma EBITDA$740K
Current Margin-1.1%
Pro Forma Margin6.3%
WC Released (1x)$451K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-200K$7.8M0.00x-100.0%
Base (11x exit)10.0x11.0x$-200K$8.6M0.00x-100.0%
Bull Case9.0x11.0x$-180K$11.4M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-180K$12.3M0.00x-100.0%
Bear Case11.0x10.0x$-220K$3.6M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-220K$3.8M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 59 hospitals with 25-100 beds
  • Same-state prioritization (n=60)
  • Comp margins: P25=-24.0% / P50=-13.9% / P75=6.0%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.